The history of the angiogenic switch concept (Q36600928)

15 August 2017

1 reference

title

The history of the angiogenic switch concept (English)

1 reference

15 August 2017

Ribatti D

1

1 reference

15 August 2017

Nico B

2

1 reference

15 August 2017

Crivellato E

3

1 reference

15 August 2017

Roccaro AM

4

1 reference

15 August 2017

Vacca A

5

1 reference

15 August 2017

21 September 2006

1 reference

15 August 2017

9

1 reference

inferred from page(s)

published in

Leukemia

1 reference

15 August 2017

21

1 reference

15 August 2017

1

1 reference

15 August 2017

44-52

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404402

15 August 2017

0 references

cites work

The role of the vascular phase in solid tumor growth: a historical review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Induction of angiogenesis during the transition from hyperplasia to neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Interactions between newly formed endothelial channels and carcinoma cells in plasma clot culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Angiogenesis: A Marker for Neoplastic Transformation of Mammary Papillary Hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Angiogenesis as a marker of preneoplastic lesions of the human breast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Origin of endothelial progenitors in human postnatal bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Current biology of VEGF-B and VEGF-C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

The Angiogenic and Lymphangiogenic Factor Vascular Endothelial Growth Factor-D Exhibits a Paracrine Mode of Action in Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Abstracts of the joint meeting of the Pathological Society of Great Britain and Ireland and the Dutch Pathological Society, 186th meeting of the Pathological Society of Great Britain and Ireland. 6-9 July 2004, Amsterdam, The Netherlands

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Postnatal vasculogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Endothelial cell development, vasculogenesis, angiogenesis, and tumor neovascularization: an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Lymphangiogenesis in malignant tumours: Does it occur?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

The role of tumor lymphangiogenesis in metastatic spread.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Identification of substituted 3-[(4,5,6, 7-tetrahydro-1H-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as growth factor receptor inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rbeta tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Lymphatic vessels as targets of tumor therapy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Metastasis and angiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

How tumors become angiogenic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

1 reference

7 January 2021

Specialization of tumour vasculature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Genetic instabilities in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

The multistep nature of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Insight into the physiological functions of PDGF through genetic studies in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Antiangiogenic therapy of transgenic mice impairs de novo tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Cell-heritable stages of tumor progression in transgenic mice harboring the bovine papillomavirus type 1 genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Transcription factors junB and c-jun are selectively up-regulated and functionally implicated in fibrosarcoma development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404402

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404402

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference